The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

doi:10.1001/jamaneurol.2020.4835

Review

. 2021 Apr 1;78(4):379-380.

doi: 10.1001/jamaneurol.2020.4835.

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Emily A Largent¹, Anna Wexler¹, Jason Karlawish^{1

2}

Affiliations

¹ Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
² Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 33393982
PMCID: PMC8035155
DOI: 10.1001/jamaneurol.2020.4835

Review

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Emily A Largent et al. JAMA Neurol. 2021.

. 2021 Apr 1;78(4):379-380.

doi: 10.1001/jamaneurol.2020.4835.

Authors

Emily A Largent¹, Anna Wexler¹, Jason Karlawish^{1

2}

Affiliations

¹ Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.
² Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 33393982
PMCID: PMC8035155
DOI: 10.1001/jamaneurol.2020.4835

No abstract available

PubMed Disclaimer

Cited by

Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.
Grill JD, Raman R, Ernstrom K, Wang S, Donohue MC, Aisen PS, Karlawish J, Henley D, Romano G, Novak G, Brashear HR, Sperling RA. Grill JD, et al. Neurol Clin Pract. 2024 Apr;14(2):e200265. doi: 10.1212/CPJ.0000000000200265. Epub 2024 Jan 12. Neurol Clin Pract. 2024. PMID: 38585443
Ethical issues in direct-to-consumer healthcare: A scoping review.
Nagappan A, Kalokairinou L, Wexler A. Nagappan A, et al. PLOS Digit Health. 2024 Feb 13;3(2):e0000452. doi: 10.1371/journal.pdig.0000452. eCollection 2024 Feb. PLOS Digit Health. 2024. PMID: 38349902 Free PMC article.
The Return of Biomarker Results in Research: Balancing Complexity, Precision, and Ethical Responsibility.
Robillard JM, Masellis M, Martin SE, Khachaturian AS, Dixon RA. Robillard JM, et al. J Alzheimers Dis. 2024;97(3):1083-1090. doi: 10.3233/JAD-230359. J Alzheimers Dis. 2024. PMID: 38306053 Free PMC article. Review.
Associations of Everyday and Lifetime Experiences of Discrimination With Willingness to Undergo Alzheimer Disease Predictive Testing.
Hill-Jarrett TG, Choi M, Buto PT, Miramontes S, Thomas MD, Yang Y, Kim MH, Sims KD, Glymour MM. Hill-Jarrett TG, et al. Neurology. 2024 Feb 27;102(4):e208005. doi: 10.1212/WNL.0000000000208005. Epub 2024 Jan 24. Neurology. 2024. PMID: 38266219
Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort.
Erickson CM, Chin NA, Rosario HL, Peterson A, Johnson SC, Clark LR. Erickson CM, et al. Alzheimers Dement (N Y). 2023 Jul 29;9(3):e12413. doi: 10.1002/trc2.12413. eCollection 2023 Jul-Sep. Alzheimers Dement (N Y). 2023. PMID: 37521522 Free PMC article.

See all "Cited by" articles

References

1. Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. Published online July 28, 2020. doi:10.1001/jama.2020.12134 - DOI - PMC - PubMed
1. Leavitt SA. “A Private Little Revolution”: The Home Pregnancy Test in American Culture. Bulletin of the History of Medicine. 2006;80(2):317–346. - PubMed
1. Sheffrin M, Stijacic Cenzer I, Steinman MA. Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study. Alz Res Therapy. 2016;8(1):55. doi:10.1186/s13195-016-0223-9 - DOI - PMC - PubMed
1. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine. 2011;13(6):597–605. doi:10.1097/GIM.0b013e31821d69b8 - DOI - PMC - PubMed
1. Largent EA, Harkins K, van Dyck CH, Hachey S, Sankar P, Karlawish J. Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results. PLOS ONE. 2020;15(2):e0229137. doi:10.1371/journal.pone.0229137 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. Published online July 28, 2020. doi:10.1001/jama.2020.12134 - DOI - PMC - PubMed

[2] Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA. Published online July 28, 2020. doi:10.1001/jama.2020.12134 - DOI - PMC - PubMed

[3] Leavitt SA. “A Private Little Revolution”: The Home Pregnancy Test in American Culture. Bulletin of the History of Medicine. 2006;80(2):317–346. - PubMed

[4] Leavitt SA. “A Private Little Revolution”: The Home Pregnancy Test in American Culture. Bulletin of the History of Medicine. 2006;80(2):317–346. - PubMed

[5] Sheffrin M, Stijacic Cenzer I, Steinman MA. Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study. Alz Res Therapy. 2016;8(1):55. doi:10.1186/s13195-016-0223-9 - DOI - PMC - PubMed

[6] Sheffrin M, Stijacic Cenzer I, Steinman MA. Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study. Alz Res Therapy. 2016;8(1):55. doi:10.1186/s13195-016-0223-9 - DOI - PMC - PubMed

[7] Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine. 2011;13(6):597–605. doi:10.1097/GIM.0b013e31821d69b8 - DOI - PMC - PubMed

[8] Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genetics in Medicine. 2011;13(6):597–605. doi:10.1097/GIM.0b013e31821d69b8 - DOI - PMC - PubMed

[9] Largent EA, Harkins K, van Dyck CH, Hachey S, Sankar P, Karlawish J. Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results. PLOS ONE. 2020;15(2):e0229137. doi:10.1371/journal.pone.0229137 - DOI - PMC - PubMed

[10] Largent EA, Harkins K, van Dyck CH, Hachey S, Sankar P, Karlawish J. Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan results. PLOS ONE. 2020;15(2):e0229137. doi:10.1371/journal.pone.0229137 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Affiliations

The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical